|
Sep 26
|
Buy These 5 Big Drug Stocks to Boost Your Portfolio's Health
|
|
Sep 26
|
AstraZeneca in AI collaboration with Immunai to inform cancer drug trials
|
|
Sep 26
|
Deutsche Bank ADR Virtual Investor Conference: Presentations Now Available for Online Viewing
|
|
Sep 26
|
TAGRISSO® (osimertinib) approved in the US for patients with unresectable, Stage III EGFR-mutated lung cancer
|
|
Aug 30
|
QIAGEN and AstraZeneca Expand Pact to Develop CDx in Chronic Diseases
|
|
Aug 29
|
Why Is Merck (MRK) Up 3.8% Since Last Earnings Report?
|
|
Aug 29
|
Qiagen, AstraZeneca expand companion diagnostic pact beyond cancer
|
|
Aug 29
|
The Zacks Analyst Blog Highlights Visa, AstraZeneca, Disney, FitLife Brands and Utah Medical
|
|
Aug 29
|
3 UK Stocks Estimated To Be Trading At Up To 46.9% Discount
|
|
Aug 28
|
Top Analyst Reports for Linde, AstraZeneca & Walt Disney
|
|
Aug 28
|
AstraZeneca PLC (AZN): A Cheap Pharmaceutical Stock to Buy According to Short Sellers
|
|
Aug 28
|
Five alternatives to Mag 7 stocks if you missed out on Nvidia
|
|
Aug 26
|
AstraZeneca (AZN) Denies Rumors About UK Facility Relocation
|
|
Jul 30
|
AstraZeneca reports positive data from chronic lymphocytic leukaemia therapy trial
|
|
Jul 30
|
NICE not to recommend Daiichi Sankyo-AstraZeneca’s Enhertu for NHS
|
|
Jul 29
|
Fixed-duration CALQUENCE® (acalabrutinib) plus venetoclax, with or without obinutuzumab, significantly improved progression-free survival in 1st-line chronic lymphocytic leukemia in AMPLIFY Phase III trial
|
|
Jul 28
|
AstraZeneca (LON:AZN) Has Announced A Dividend Of $0.776
|
|
Jul 27
|
AstraZeneca Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
|
|
Jul 26
|
FDA committee proposes overhaul of perioperative lung cancer trials
|
|
Jul 26
|
3 Surprisingly Underrated Stocks to Buy Right Now
|